American Heart Association Scientific Sessions

Healio brings you the highlights from the American Heart Association Scientific Sessions. Refer back to this page often for the latest news from AHA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

How to encourage nutrition over pills to manage cholesterol

January 31, 2019
Consuming two doses of foods containing high levels of whole food fiber, omega-3 fatty acids and phytosterols per day significantly reduced LDL…
Meeting News

Lipid-lowering agents reduce risk for CV events, but not inflammation

January 7, 2019
CHICAGO – Agents that decrease LDL cholesterol levels also reduce the risk for major adverse CV events, though they do not limit inflammation…
Meeting News

Long-term risk assessment increases number of patients eligible for statins

January 4, 2019
CHICAGO – A 30-year risk threshold doubled the number of patients designated as eligible for statin therapy in primary care, according to…
Meeting News

Guest Commentary: DECLARE-TIMI 58 trial validates CV benefits of SGLT2 inhibitors in type 2 diabetes

January 4, 2019
Results from the DECLARE-TIMI 58 trial, presented during a late-breaking session at the 2018 American Heart Association Scientific Sessions, add to
Meeting News

Cardiologists should recognize CV benefit, increase prescribing of SGLT2 inhibitors, GLP-1 receptor agonists

January 1, 2019
CHICAGO —A speaker at the American Heart Association Scientific Sessions called on cardiologists to become more involved in the use of SGLT2…
Meeting NewsPerspective

Cell therapy fails to improve cardiac recovery in advanced HF

December 20, 2018
CHICAGO — Among patients with advanced HF designated for left ventricular assist device therapy, mesenchymal precursor cells did not improve…
Meeting News

Speaker highlights concordance of studies, BP guidelines in diabetes

December 20, 2018
CHICAGO — Data from multiple trials show a similar effect of systolic BP lowering on CV outcomes between patients with diabetes and those…
Meeting News

Data support intensive lipid-lowering therapy in diabetes

December 18, 2018
CHICAGO — Although recent trials indicate intensive lipid-lowering therapy is advantageous for patients with diabetes, specific LDL targets…
Meeting News

Alirocumab lowers LDL cholesterol in hypercholesterolemia

December 18, 2018
CHICAGO – Alirocumab decreases LDL cholesterol in a “clinically meaningful way” among patients with autosomal dominant…
Meeting News

Q&A: A closer look at class effects of SGLT2 inhibitors on CV outcomes in diabetes

December 17, 2018
An expert consensus decision pathway recently published by the American College of Cardiology highlights studies that show SGLT2 inhibitors…